Skip to main content
logo
Shin Nippon Biomedical Laboratories, Ltd. (FRA:YB3)
Germany flag Germany · Delayed Price · Currency is EUR
10.70
+0.40 (3.88%)
At close: Dec 15, 2025

Revenue by Product

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2003 - 2019
Contract Research Organization
31.51B
Log In
Log In
Log In
Log In
Upgrade
Contract Research Organization Growth
22.81%
Log In
Log In
Log In
Log In
Upgrade
Medipolis
470.40M
Log In
Log In
Log In
Log In
Upgrade
Medipolis Growth
-1.50%
Log In
Log In
Log In
Log In
Upgrade
Translational Research
54.16M
Log In
Log In
Log In
Log In
Upgrade
Translational Research Growth
364.10%
Log In
Log In
Log In
Log In
Upgrade
United States Real Estate
45.98M
Log In
Log In
Log In
Log In
Upgrade
Other
328.74M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
9.42%
Log In
Log In
Log In
Log In
Upgrade
Other
328.74M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
9.42%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2003 - 2019
Other
498.21M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
26.70%
Log In
Log In
Log In
Log In
Upgrade
Japan
21.52B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
20.84%
Log In
Log In
Log In
Log In
Upgrade
United States
6.37B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
42.18%
Log In
Log In
Log In
Log In
Upgrade
South Korea
4.02B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
6.79%
Log In
Log In
Log In
Log In
Upgrade
Other
498.21M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
26.70%
Log In
Log In
Log In
Log In
Upgrade